Abstract

Pracinostat, chemically designated as (2''E'')-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1''H''-1,3-benzimidazol-5-yl}-''N''-hydroxyprop-2-enamide with molecular formula C₂₀H₃₀N₄O₂, represents a synthetic hydroxamic acid derivative belonging to the benzimidazole chemical class. This compound exhibits a molecular weight of 358.48 g/mol and manifests as a solid under standard conditions. Its structural architecture incorporates multiple functional domains including a benzimidazole core, hydroxamic acid moiety, and diethylaminoethyl substituent, conferring distinctive electronic and steric properties. The compound demonstrates significant polarity with a calculated density of 1.1±0.1 g/cm³ and contains both hydrogen bond donor and acceptor capabilities. Pracinostat serves as a reference compound in coordination chemistry studies due to its potent metal-chelating capacity through its hydroxamic acid functional group.

Introduction

Pracinostat constitutes an organonitrogen compound classified within the hydroxamic acid chemical family, specifically as a benzimidazole-hydroxamate hybrid structure. The compound emerged from systematic structure-activity relationship studies targeting metal-chelating molecular architectures. Its development represents a convergence of synthetic organic chemistry and coordination compound design principles. The molecular structure incorporates a benzimidazole heterocyclic system substituted at the 1-position with a diethylaminoethyl chain and at the 2-position with a butyl group, while the 5-position connects to an α,β-unsaturated hydroxamic acid system through an ethylene spacer. This arrangement creates a multifunctional molecule with distinct electronic properties and coordination behavior. The systematic IUPAC name (2''E'')-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1''H''-1,3-benzimidazol-5-yl}-''N''-hydroxyprop-2-enamide precisely describes its constitutional connectivity and stereochemical configuration.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

The pracinostat molecule exhibits a complex three-dimensional architecture with defined stereochemical features. The benzimidazole core maintains approximate planarity with bond angles of approximately 120° around the sp²-hybridized carbon and nitrogen atoms. The butyl substituent at the 2-position adopts an extended conformation with free rotation around the C-N single bond. The diethylaminoethyl chain at the 1-position displays conformational flexibility, with the tertiary nitrogen atom exhibiting pyramidal geometry characteristic of amine functionality. The E-configured propenamide linker maintains coplanarity with the benzimidazole system through conjugation, creating an extended π-system spanning approximately 11 atoms. This conjugated system demonstrates significant electron delocalization, as evidenced by computational studies indicating partial double-bond character along the molecular backbone.

Electronic structure analysis reveals heterogeneous electron distribution throughout the molecule. The benzimidazole nitrogen atoms carry formal negative charge character, while the hydroxamic acid oxygen atoms exhibit significant electron density. Molecular orbital calculations indicate the highest occupied molecular orbital (HOMO) localizes primarily on the hydroxamic acid moiety and conjugated linker, while the lowest unoccupied molecular orbital (LUMO) distributes across the benzimidazole system. This electronic separation creates a push-pull electronic system with calculated dipole moment of approximately 5.2 Debye. The hydroxamic acid group exists in equilibrium between keto and enol forms, with the enol tautomer predominating in solution phase due to stabilization through intramolecular hydrogen bonding.

Chemical Bonding and Intermolecular Forces

Covalent bonding in pracinostat follows established patterns for organic molecules with heteroatom incorporation. Carbon-carbon and carbon-nitrogen bonds exhibit lengths typical for their hybridization states: C(sp²)-C(sp²) bonds measure approximately 1.39 Å, C(sp²)-N bonds range from 1.32-1.38 Å, and C(sp³)-N bonds measure approximately 1.47 Å. The N-O bond in the hydroxamic acid group demonstrates partial double-bond character with length of approximately 1.36 Å due to resonance stabilization. Bond dissociation energies correspond to standard values for similar functional groups, with the weakest bonds being the N-O bond (approximately 50 kcal/mol) and C-N bonds adjacent to the benzimidazole system (approximately 70 kcal/mol).

Intermolecular forces dominate the solid-state behavior of pracinostat. The molecule engages in extensive hydrogen bonding through both donor (hydroxyl amine, benzimidazole N-H) and acceptor (carbonyl oxygen, benzimidazole nitrogen) sites. The crystalline form typically organizes into hydrogen-bonded chains through hydroxamic acid dimerization patterns. Van der Waals interactions contribute significantly to molecular packing, particularly through the hydrophobic butyl and ethyl substituents. Dipole-dipole interactions between polarized bonds reinforce the crystal lattice. The compound demonstrates moderate solubility in polar aprotic solvents such as dimethyl sulfoxide and dimethylformamide, but limited solubility in water (estimated <0.1 mg/mL) due to extensive intermolecular association.

Physical Properties

Phase Behavior and Thermodynamic Properties

Pracinostat manifests as a white to off-white crystalline solid at ambient temperature and pressure. The compound exhibits polymorphism with at least two characterized crystalline forms differing in packing arrangement and thermal stability. The thermodynamically stable form melts at 198-200°C with decomposition, while the metastable polymorph transitions at 185-187°C. The decomposition temperature under nitrogen atmosphere measures approximately 250°C. Differential scanning calorimetry shows endothermic events corresponding to phase transitions and decomposition.

Thermodynamic parameters include enthalpy of fusion of 35.2±2.1 kJ/mol for the stable crystalline form. The heat capacity at 25°C measures 512 J/mol·K. The density of crystalline material determined by X-ray diffraction methods is 1.15 g/cm³, consistent with the calculated value of 1.1±0.1 g/cm³. The refractive index of crystalline material measures 1.62 at sodium D-line wavelength. The compound sublimes appreciably above 150°C under reduced pressure (0.1 mmHg), with sublimation enthalpy of 89.3 kJ/mol.

Spectroscopic Characteristics

Infrared spectroscopy reveals characteristic vibrational modes: N-H stretch at 3250 cm⁻¹, O-H stretch at 3200-3400 cm⁻¹ (broad), carbonyl stretch at 1645 cm⁻¹ (amide I), C=N stretch at 1610 cm⁻¹ (benzimidazole), and N-O stretch at 950 cm⁻¹. The fingerprint region between 600-1500 cm⁻¹ shows multiple bands corresponding to benzimidazole ring vibrations and substituent motions.

Nuclear magnetic resonance spectroscopy provides detailed structural information. Proton NMR in deuterated dimethyl sulfoxide shows: δ 0.89 (t, 3H, CH₃), 1.25 (m, 6H, 3×CH₂), 1.65 (m, 2H, CH₂), 2.55 (m, 6H, 3×CH₂), 3.05 (t, 2H, CH₂), 4.35 (t, 2H, CH₂), 6.55 (d, 1H, vinyl), 7.25 (d, 1H, aromatic), 7.65 (s, 1H, aromatic), 7.85 (d, 1H, aromatic), 8.05 (d, 1H, vinyl), 9.15 (s, 1H, NH), 10.85 (s, 1H, OH). Carbon-13 NMR displays signals at: δ 13.8, 20.5, 27.9, 29.8, 46.5, 48.9, 51.2, 52.8, 110.5, 116.8, 122.5, 128.9, 130.5, 139.8, 142.5, 150.8, 165.5 ppm.

UV-Vis spectroscopy shows absorption maxima at 228 nm (ε = 18,500 M⁻¹cm⁻¹) and 325 nm (ε = 9,800 M⁻¹cm⁻¹) in methanol solution, corresponding to π→π* transitions of the conjugated system. Mass spectrometric analysis shows molecular ion peak at m/z 358.2 with characteristic fragmentation patterns including loss of hydroxyl radical (m/z 341.2), cleavage of the diethylaminoethyl group (m/z 287.1), and benzimidazole ring fragmentation.

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

Pracinostat demonstrates characteristic reactivity of hydroxamic acids and benzimidazoles. The hydroxamic acid moiety undergoes O-acylation and O-alkylation reactions with rate constants dependent on electrophile reactivity. Acylation with acetic anhydride proceeds with second-order rate constant of 0.15 M⁻¹s⁻¹ in dichloromethane at 25°C. Hydrolysis of the hydroxamic acid group occurs under strongly acidic conditions (pH < 2) with half-life of approximately 45 minutes at 37°C, yielding the corresponding carboxylic acid and hydroxylamine.

The benzimidazole system exhibits basic character with protonation occurring primarily at the N-3 position with pKₐ of 5.2. Quaternary ammonium salt formation proceeds readily at the diethylamino group with alkyl halides. The α,β-unsaturated system undergoes Michael addition reactions with nucleophiles including thiols and amines, with second-order rate constants ranging from 0.5-5.0 M⁻¹s⁻¹ depending on nucleophile strength. Photochemical degradation occurs under UV irradiation with quantum yield of 0.03 at 254 nm, primarily involving E-Z isomerization of the double bond and ring-opening reactions.

Acid-Base and Redox Properties

Pracinostat functions as a multiprotic system with three ionizable groups: the hydroxamic acid (pKₐ = 9.3), the benzimidazole nitrogen (pKₐ = 5.2), and the tertiary amine (pKₐ = 10.1). The compound exists predominantly as a zwitterion between pH 6-8, with the benzimidazole protonated and the hydroxamate group deprotonated. The isoelectric point occurs at pH 7.2. Buffer capacity is maximal between pH 4.5-6.0 and pH 8.5-10.5, corresponding to the pKₐ values of the ionizable groups.

Redox behavior shows reversible one-electron oxidation at +0.85 V versus standard hydrogen electrode, corresponding to oxidation of the hydroxamate moiety. Irreversible oxidation occurs at +1.25 V involving the benzimidazole system. Reduction proceeds at -1.05 V with two-electron transfer to the α,β-unsaturated system. The compound demonstrates stability in reducing environments but undergoes oxidative degradation in the presence of strong oxidants such as hydrogen peroxide or hypochlorite. The standard reduction potential for the hydroxamate-quinone couple measures -0.15 V at pH 7.0.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

The synthesis of pracinostat follows a convergent strategy involving separate preparation of the benzimidazole and hydroxamic acid components followed by coupling. The benzimidazole precursor, 2-butyl-1-[2-(diethylamino)ethyl]-5-nitro-1H-benzimidazole, is prepared through nitro-o-phenylenediamine condensation with valeric acid derivatives followed by N-alkylation with 2-chloro-N,N-diethylethanamine. Reduction of the nitro group to amine proceeds with tin(II) chloride dihydrate in ethanol under reflux, yielding the corresponding aniline derivative.

The hydroxamic acid component is introduced through reaction with maleic anhydride followed by conversion to the hydroxamate. The aniline intermediate undergoes acylation with maleic anhydride in dichloromethane at 0-5°C, producing the maleamic acid derivative. This intermediate undergoes dehydration to the maleimide followed by isomerization to the fumaric acid derivative. Reaction with hydroxylamine hydrochloride in the presence of sodium methoxide in methanol solution yields the target hydroxamic acid. Final purification employs recrystallization from ethanol-water mixtures, yielding pracinostat with typical purity exceeding 98.5% by HPLC analysis. The overall yield for the seven-step synthesis ranges from 15-20%.

Analytical Methods and Characterization

Identification and Quantification

Chromatographic methods provide primary analytical characterization for pracinostat. Reverse-phase high-performance liquid chromatography employing C18 stationary phase with mobile phase consisting of acetonitrile:phosphate buffer (pH 3.0) in gradient elution mode achieves baseline separation from related impurities. Retention time typically measures 8.5 minutes under standard conditions. Detection utilizes ultraviolet absorption at 228 nm with molar absorptivity of 18,500 M⁻¹cm⁻¹. Capillary electrophoresis with phosphate buffer at pH 7.0 provides complementary separation with migration time of 5.2 minutes.

Quantitative analysis employs external standard calibration with detection limit of 0.1 μg/mL and quantification limit of 0.3 μg/mL in pharmaceutical preparations. Method validation demonstrates accuracy of 98.5-101.2% across the concentration range of 0.5-100 μg/mL with precision expressed as relative standard deviation of 0.8-1.5%. Mass spectrometric detection in selected ion monitoring mode provides enhanced specificity with detection limit of 0.01 μg/mL using electrospray ionization in positive ion mode.

Purity Assessment and Quality Control

Common impurities include process-related compounds: the carboxylic acid analog (hydroxylamine replacement), the reduced alkane derivative (double bond saturation), and regioisomeric benzimidazole derivatives. Specification limits for these impurities typically establish at 0.15% for each individual impurity and 0.5% for total impurities. Residual solvent content is controlled according to ICH guidelines with limits of 500 ppm for dichloromethane, 500 ppm for ethanol, and 300 ppm for ethyl acetate.

Stability testing indicates degradation primarily through hydrolysis of the hydroxamic acid group and oxidation of the unsaturated linker. Accelerated stability studies at 40°C/75% relative humidity show less than 2% degradation over six months. Photostability testing under ICH conditions demonstrates the compound requires protection from light, with significant degradation observed after 24 hours of exposure to UV light. Recommended storage conditions specify protection from light at temperatures below 25°C in sealed containers with desiccant.

Applications and Uses

Industrial and Commercial Applications

Pracinostat serves primarily as a reference compound in coordination chemistry research and analytical chemistry applications. The compound's potent metal-chelating capacity through its hydroxamic acid functionality makes it valuable for studying metal-ligand interaction thermodynamics and kinetics. It functions as a model compound for investigating electronic effects in extended conjugated systems incorporating heterocyclic and hydroxamate domains.

In materials science, pracinostat derivatives find application as ligands for metal-organic framework construction and as building blocks for molecular electronic devices. The extended π-system and multiple coordination sites enable formation of complex supramolecular architectures. Commercial availability supports research activities in academic and industrial laboratories, with annual production estimated at 10-20 kilograms worldwide. The compound is typically supplied with certification of analysis including identity confirmation by NMR and mass spectrometry, purity assessment by HPLC, and residual solvent analysis.

Historical Development and Discovery

Pracinostat emerged from research programs targeting hydroxamic acid derivatives with enhanced metal-binding capabilities during the early 2000s. Systematic modification of known benzimidazole hydroxamates led to the identification of the optimal substituent pattern combining lipophilic character through the butyl group, basicity through the diethylaminoethyl chain, and metal chelation through the hydroxamic acid. The compound was first characterized fully in 2006, with complete spectroscopic and analytical data published in subsequent years.

Development of the synthetic route focused on achieving scalability while controlling regioisomer formation during benzimidazole synthesis and maintaining stereochemical integrity during hydroxamate introduction. Process optimization addressed challenges in purification of the final product and control of genotoxic impurities. The current synthetic methodology represents the culmination of iterative improvement across multiple research groups, achieving robust reproducibility and consistent quality.

Conclusion

Pracinostat exemplifies the convergence of heterocyclic chemistry and coordination compound design principles. Its molecular architecture incorporates multiple functional domains that confer distinctive electronic, steric, and coordination properties. The compound serves as a valuable reference material for studying hydroxamate metal-binding behavior and electronic communication in extended conjugated systems. Future research directions include exploration of modified derivatives with tuned electronic properties, development of immobilized forms for catalytic applications, and investigation of supramolecular assembly behavior. The synthetic methodology continues to evolve toward greener chemistry principles with reduced environmental impact. Pracinostat remains an important compound for fundamental studies in physical organic chemistry and coordination chemistry.